Drug Detail

Information about Tasigna + Gleevec

Generic Name	Nilotinib + Imatinib
IND
Brand Name (US)	Tasigna + Gleevec
Manufacturer	Novartis
Drug Type	Tyrosine Kinase Inhibitor
Delivery	Oral
Approval Status	Both are approved
Indications
Overall Strategy	KIT Protein Based
Strategy	Block KIT
Drug Category	KIT inhibitor

Links
Trials of this drug
	Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Trial results

Search for this drug/combination in:

ClinicalTrials.gov